Which has grown faster, ACAD or TNGX?

Over the past five years, ACAD grew revenue faster — ACAD at a 19.70% CAGR versus TNGX at 19.14%.

Is ACAD or TNGX more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus TNGX at -229.92%.

How have ACAD and TNGX total returns compared?

Over the past 5 years, ACAD delivered 3.52% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs Tango Therapeutics, Inc. (TNGX)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.38B

$19.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TNGX

Tango Therapeutics, Inc.

$3.57B

$21.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ACAD vs TNGX

growth of $100 · dividends reinvested · last 6y

ACAD -47.1% (-10.1%/yr)TNGX +125.6% (+14.5%/yr)TNGX compounded faster over this window

ACAD TNGX

ACAD vs TNGX: by the numbers

•TNGX is the larger company ($3.57B vs $3.38B market cap).
•ACAD is profitable (33.42% net margin) while TNGX runs a net loss (-229.92%).
•ACAD grew revenue faster over the past five years (19.70% vs 19.14% CAGR).

Metrics side by side

Valuation

Metric	ACAD	TNGX
P/E ratio	8.89	N/A
Forward P/E	32.05	N/A
P/S ratio	2.97	66.26
P/B ratio	2.59	3.48
EV / EBITDA	31.19	N/A
FCF yield	5.16%	N/A

Profitability

Metric	ACAD	TNGX
Gross margin	91.13%	98.25%
Operating margin	7.59%	-178.39%
Net margin	33.42%	-229.92%
ROE	29.12%	-12.08%
ROIC	6.25%	-12.91%

Growth (annualized)

Metric	ACAD	TNGX
Revenue CAGR (5Y)	19.70%	19.14%
Total return CAGR (5Y)	3.52%	10.60%

Frequently asked

Which has grown faster, ACAD or TNGX?: Over the past five years, ACAD grew revenue faster — ACAD at a 19.70% CAGR versus TNGX at 19.14%.
Is ACAD or TNGX more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus TNGX at -229.92%.
How have ACAD and TNGX total returns compared?: Over the past 5 years, ACAD delivered 3.52% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full TNGX analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio Acadia Pharmaceuticals ROE Tango Therapeutics ROE Acadia Pharmaceuticals operating margin Tango Therapeutics operating margin Acadia Pharmaceuticals revenue growth Tango Therapeutics revenue growth Acadia Pharmaceuticals free cash flow Tango Therapeutics free cash flow

Acadia Pharmaceuticals & Tango Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.